Immunoexpression of p53 and cyclic D1 in adenomas of the gallbladder;Inmunoexpresión de p53 y ciclina D1 en adenomas de vesícula biliar

Revista Espanola de Enfermedades Digestivas

Volumn 99, Issue 12, 2007, Pages 694-697

  Arévalo, Fernando ^a   Arias Stella, C ^a   Monge, E ^b  

^a Instituto Patología y Biología Molecular Arias Stella   (Peru)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

Author keywords

Cyclin D1; Gallbladder adenocarcinoma; Gallbladder adenoma; p53

Indexed keywords

CYCLIN D1; PROTEIN P53;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GALLBLADDER ADENOCARCINOMA; GALLBLADDER ADENOMA; GALLBLADDER CARCINOMA; GALLBLADDER TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADENOMA; ADULT; CROSS-SECTIONAL STUDIES; CYCLIN D1; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; MALE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 40949121939     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Mills S, Carter D. Sternberg diagnostic surgical pathology. 4th ed. Lippincott; 2004.
2. Hui AM, Li X, Shi YZ, Takayama T, Torzilli G, Makuuchi M. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer 2000; 6: 4272-7.
3. Ma HB, Hu HT, Di Z L, et al. Association of cyclin D1, p16 and retinoblastoma protein expression with prognosis and metastasis of gallbladder carcinoma. World J Gastroenterol 2005; 11: 744-7.
4. Roa I, Melo A, Roa J, Araya J, Villaseca M, de Aretxabala X. P53 gene mutation in gallbladder cancer. Rev Méd Chile 2000; 128: 251-8.
5. Roa I , Melo A, Roa J, et al. Gen supresor de tumores p53 en neoplasias digestivas. Rev Méd Chile 2000; 128: 1269-78.
6. Billo P, Marchegiani C, Capella C, Sessa F. Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa. Pathologica 2000; 92: 249-56.
7. Watanabe H, Date K, Itoi T, Matsubayashi H, Yokoyama N, Yamano M, et al. Histological and genetic changes in malignant transformation of gallbladder adenoma. Ann Oncol 1999; 10: 136-9.
8. Wang SN, Chung SC, Tsai KB, Chai CY. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma. Kaohsiung. J Med Sci 2006; 22: 53-9.
9. Chaube A, Tewari M, Garbyal RS, Singh U, Shukla HS. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript. BMC Cancer 2006; 6: 126.
10. Wistuba Miquel JF, Gazdar AF, Albores-Saavedra J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 1999; 30: 21-5.
11. Roa I, de Aretxabala X, Araya JC, et al. Preneoplastic lesions in gallbladder cancer. J Surg Oncol 2006; 93: 615-23.